38 results on '"De Hert M"'
Search Results
2. Affective wellbeing moderates the association between polygenic risk score for neuroticism and change in neuroticism
3. Differential associations of childhood adversity subtypes and psychopathology in men and women
4. Eurofit test battery in patients with schizophrenia or schizoaffective disorder: Reliability and clinical correlates
5. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
6. Second-generation antipsychotics and constipation: A review of the literature
7. Euthanasia of a person with a psychiatric disorder does not violate the European Convention on Human Rights (Mortier v. Belgium [no. 78017/17])
8. Physical health management in psychiatric settings
9. Management of physical health in patients with schizophrenia: practical recommendations
10. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
11. A study of the family burden of 150 family members of schizophrenic patients
12. A roadmap to disentangle the molecular etiology of schizophrenia
13. Is sensitivity to daily stress predictive of onset or persistence of psychopathology?
14. PW01-158 - Differentials effects of olanzapine and risperidone on plasma adiponectin levels over time: a prospective study
15. Dysmetabolic features of the overweight patients receiving antipsychotic drugs: A comparison with normal weight and obese subjects
16. EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness
17. EPA-0679 - Stigmatization of schizophrenia in flemish newspapers
18. EPA-0809 - Aripiprazole once-monthly for the treatment of schizophrenia in obese and non-obese patients; a post-hoc analysis
19. EPA-1616 - EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness
20. 2584 – Comparison of metabolic syndrome incidence among schizophrenia patients treated with asenapine versus olanzapine
21. 2960 – Importance of physical health in the long-term management of bipolar I disorders
22. CS01-04 - Psychotic disorders and increased metabolic and cardiovascular morbidity in patients with schizophrenia. recommendation for diagnoses and treatment
23. Physical health problems in serious mental illness — Possible solutions
24. A systematic evaluation and comparison of the guidelines for screening and monitoring of cardiometabolic risk in people with schizophrenia
25. Prediabetes in patients treated with antipsychotic drugs
26. WITHDRAWN: Maladie cardiovasculaire et diabète chez les sujets souffrant d’une maladie mentale sévère. Déclaration de position de l’European Psychiatric Association (EPA), soutenue par l’European Association for the Study of Diabetes (EASD) et l’European Society of Cardiology (ESC)
27. PW01-199 - Barriers To Physical Health Care In People With Mental Illness
28. P02-178 - BMI Directly Relates to Glycaemia in Patients with Severe Enduring Mental Illness
29. Epidemiological Study for the Evaluation of Metabolic Disorders in Patients with Schizophrenia: The Meteor Study
30. Impact of antipsychotic treatment on physical health
31. Preliminary results of the Belgian lifestyle program ENERGIE on weight in patients with psychiatric disorders
32. Sexual dysfunction: The unspoken side effect of antipsychotics
33. Suicide in young schizophrenic patients, a case control study
34. W01-03 - A systematic evaluation and comparison of the guidelines for screening and monitoring of cardiometabolic risk in people with schizophrenia
35. S39-01 - Physical health problems in serious mental illness — Possible solutions
36. P02-568 - Prediabetes in patients treated with antipsychotic drugs
37. P03-135 Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: The meteor study
38. WITHDRAWN: Maladie cardiovasculaire et diabète chez les sujets souffrant d’une maladie mentale sévère. Déclaration de position de l’European Psychiatric Association (EPA), soutenue par l’European Association for the Study of Diabetes (EASD) et l’European Society of Cardiology (ESC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.